ArticleFrontiers in immunology2024

Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure.

Gregor P Lotz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.